Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of 'URSA SOFT CAP. (UDCA-003)' in Fatigue Patients With Liver Dysfunction [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating URSA SOFT CAP (UDCA-003) for efficacy and safety in fatigue patients with liver dysfunction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fatigue
• Liver Dysfunction

Drugs mentioned

• URSA SOFT CAP (ursodeoxycholic acid)

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Fatigue | Phase 4 | Status: COMPLETED